The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
Open accessAbstract
BACKGROUND: The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to provide updates on cancer incidence and death rates and trends in these outcomes for the United States. This year's report includes the prevalence of comorbidity at the time of first cancer diagnosis among patients with lung, colorectal, breast, or prostate cancer and survival among cancer patients based on comorbidity level. METHODS: Data on cancer incidence were obtained from the NCI, the CDC, and the NAACCR; and data on mortality were obtained from the CDC. Long‐term (1975/1992‐2010) and short‐term (2001‐2010) trends in age‐adjusted incidence and death rates for all cancers combined and for the leading cancers among men and women were examined by joinpoint analysis. Through linkage with Medicare claims, the prevalence of comorbidity among cancer patients who were diagnosed between 1992 through 2005 residing in 11 Surveillance, Epidemiology, and End Results (SEER) areas were estimated and compared with the prevalence in a 5% random sample of cancer‐free Medicare beneficiaries. Among cancer patients, survival and the probabilities of dying of their cancer and of other causes by comorbidity level, age, and stage were calculated. RESULTS: Death rates continued to decline for all cancers combined for men and women of all major racial and ethnic groups and for most major cancer sites; rates for both sexes combined decreased by 1.5% per year from 2001 through 2010. Overall incidence rates decreased in men and stabilized in women. The prevalence of comorbidity was similar among cancer‐free Medicare beneficiaries (31.8%), breast cancer patients (32.2%), and prostate cancer patients (30.5%); highest among lung cancer patients (52.9%); and intermediate among colorectal cancer patients (40.7%). Among all cancer patients and especially for patients diagnosed with local and regional disease, age and comorbidity level were important influences on the probability of dying of other causes and, consequently, on overall survival. For patients diagnosed with distant disease, the probability of dying of cancer was much higher than the probability of dying of other causes, and age and comorbidity had a smaller effect on overall survival. CONCLUSIONS: Cancer death rates in the United States continue to decline. Estimates of survival that include the probability of dying of cancer and other causes stratified by comorbidity level, age, and stage can provide important information to facilitate treatment decisions. Cancer 2014;120:1290–1314. © 2013 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Crossing the Quality Chasm: A New Health System for the 21st Century
Baker, A. (2001) · BMJ · doi:10.1136/bmj.323.7322.1192 · Cited by 10,736
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Crossing the Quality Chasm: A New Health System for the 21st Century
Committee on Quality of Health Care in America (2002) · Journal For Healthcare Quality · doi:10.1111/j.1945-1474.2002.tb00463.x · Cited by 8,483
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Cancer Epidemiology and Prevention
(2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,369
Boyd, C. M., Darer, J., Boult, C., Fried, L. P., Boult, L., & Wu, A. W. (2005) · JAMA · doi:10.1001/jama.294.6.716 · Cited by 2,581 · cited 1×
“Because of the importance of comorbidity in the care of cancer patients, prognostic and survival tools that incorporate comorbidity measures may be useful in aiding clinical decisions.(70) New tools are being developed to improve survival estimates by taking comorbidity into account.”
BackgroundScreening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
The State of US Health, 1990-2010: Burden of Diseases, Injuries, and Risk Factors
Murray, C. J. L. (2013) · JAMA · doi:10.1001/jama.2013.13805 · Cited by 2,438
Cited by
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Colorectal cancer statistics, 2017
Siegel, R. L., Miller, K. D., Fedewa, S. A., Ahnen, D. J., Meester, R. G. S., Barzi, A., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21395 · Cited by 3,806
Self-citationCancer treatment and survivorship statistics, 2014
DeSantis, C. E., Lin, C. C., Mariotto, A. B., Siegel, R. L., Stein, K. D., Kramer, J. L., Alteri, R., Robbins, A. S., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21235 · Cited by 2,779
Self-citationThe Global Burden of Cancer 2013
Fitzmaurice, C., Dicker, D., Pain, A., Hamavid, H., Moradi-Lakeh, M., MacIntyre, M. F., Allen, C., Hansen, G., Woodbrook, R., Wolfe, C., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0735 · Cited by 2,707
Self-citationOstrom, Q. T., Cioffi, G., Gittleman, H., Patil, N., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz150 · Cited by 2,585
Colorectal cancer statistics, 2014
Siegel, R., DeSantis, C., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21220 · Cited by 2,562
Self-citationOstrom, Q. T., Cioffi, G., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab200 · Cited by 2,529
Ostrom, Q. T., Gittleman, H., Fulop, J., Liu, M., Blanda, R., Kromer, C., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov189 · Cited by 2,139
Ostrom, Q. T., Gittleman, H., Truitt, G., Boscia, A., Kruchko, C., & Barnholtz-Sloan, J. S. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy131 · Cited by 2,138
Torre, L. A., Siegel, R. L., & Jemal, A. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-24223-1_1 · Cited by 1,903
Self-citationGastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Karimi, P., Islami, F., Anandasabapathy, S., Freedman, N. D., & Kamangar, F. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1057 · Cited by 1,879
Ostrom, Q. T., Gittleman, H., Liao, P., Vecchione-Koval, T., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox158 · Cited by 1,800
Ostrom, Q. T., Patil, N., Cioffi, G., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa200 · Cited by 1,789
Ostrom, Q. T., Price, M., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz-Sloan, J. S. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac202 · Cited by 1,565
Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
Jemal, A., Ward, E. M., Johnson, C. J., Cronin, K. A., Ma, J., Ryerson, A. B., Mariotto, A., Lake, A. J., Wilson, R., Sherman, R. L., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx030 · Cited by 1,556
Self-citationMachlowska, J., Baj, J., Sitarz, M., Maciejewski, R., & Sitarz, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114012 · Cited by 1,520
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
Cronin, K. A., Lake, A. J., Scott, S., Sherman, R. L., Noone, A., Howlader, N., Henley, S. J., Anderson, R. N., Firth, A. U., Ma, J., et al. (2018) · Cancer · doi:10.1002/cncr.31551 · Cited by 1,485
Self-citationOstrom, Q. T., Price, M., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz-Sloan, J. S. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad149 · Cited by 1,294
Ostrom, Q. T., Gittleman, H., Xu, J., Kromer, C., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now207 · Cited by 1,204
Ryerson, A. B., Eheman, C. R., Altekruse, S. F., Ward, J. W., Jemal, A., Sherman, R. L., Henley, S. J., Holtzman, D., Lake, A., Noone, A., et al. (2016) · Cancer · doi:10.1002/cncr.29936 · Cited by 945
Self-citationKohler, B. A., Sherman, R. L., Howlader, N., Jemal, A., Ryerson, A. B., Henry, K. A., Boscoe, F. P., Cronin, K. A., Lake, A., Noone, A.-M., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv048 · Cited by 915
Self-citationPrevalence and Costs of Skin Cancer Treatment in the U.S., 2002−2006 and 2007−2011
Guy, G. P., Machlin, S. R., Ekwueme, D. U., & Yabroff, K. R. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.08.036 · Cited by 873
Patel, S. G., Karlitz, J. J., Yen, T., Lieu, C. H., & Boland, C. R. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00426-x · Cited by 812
Rex, D. K., Boland, R. C., Dominitz, J. A., Giardiello, F. M., Johnson, D. A., Kaltenbach, T., Levin, T. R., Lieberman, D., & Robertson, D. J. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.174 · Cited by 811
Microenvironmental regulation of therapeutic response in cancer
Klemm, F., & Joyce, J. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.006 · Cited by 771
American Cancer Society nutrition and physical activity guideline for cancer survivors
Rock, C. L., Thomson, C. A., Sullivan, K. R., Howe, C. L., Kushi, L. H., Caan, B. J., Neuhouser, M. L., Bandera, E. V., Wang, Y., Robien, K., et al. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21719 · Cited by 741
Rex, D. K., Boland, C. R., Dominitz, J. A., Giardiello, F. M., Johnson, D. A., Kaltenbach, T., Levin, T. R., Lieberman, D., & Robertson, D. J. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.013 · Cited by 729
The impact of comorbidity on cancer and its treatment
Sarfati, D., Koczwara, B., & Jackson, C. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21342 · Cited by 680
Global cancer incidence in older adults, 2012 and 2035: A population‐based study
Pilleron, S., Sarfati, D., Janssen‐Heijnen, M., Vignat, J., Ferlay, J., Bray, F., & Soerjomataram, I. (2019) · International Journal of Cancer · doi:10.1002/ijc.31664 · Cited by 670
Causes of death among cancer patients
Zaorsky, N. G., Churilla, T. M., Egleston, B. L., Fisher, S. G., Ridge, J. A., Horwitz, E. M., & Meyer, J. E. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw604 · Cited by 657
Early‐onset colorectal cancer in young individuals
Mauri, G., Sartore‐Bianchi, A., Russo, A., Marsoni, S., Bardelli, A., & Siena, S. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12417 · Cited by 634
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype
Toubiana, J., Okada, S., Hiller, J., Oleastro, M., Lagos Gomez, M., Aldave Becerra, J. C., Ouachée-Chardin, M., Fouyssac, F., Girisha, K. M., Etzioni, A., et al. (2016) · Blood · doi:10.1182/blood-2015-11-679902 · Cited by 577
Annual report to the nation on the status of cancer, part 1: National cancer statistics
Cronin, K. A., Scott, S., Firth, A. U., Sung, H., Henley, S. J., Sherman, R. L., Siegel, R. L., Anderson, R. N., Kohler, B. A., Benard, V. B., et al. (2022) · Cancer · doi:10.1002/cncr.34479 · Cited by 557
Self-citationTsilimigras, D. I., Brodt, P., Clavien, P.-A., Muschel, R. J., D’Angelica, M. I., Endo, I., Parks, R. W., Doyle, M., de Santibañes, E., & Pawlik, T. M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00261-6 · Cited by 556
Price, M., Ballard, C., Benedetti, J., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., Barnholtz-Sloan, J. S., & Ostrom, Q. T. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae145 · Cited by 526
Gilchrist, S. C., Barac, A., Ades, P. A., Alfano, C. M., Franklin, B. A., Jones, L. W., La Gerche, A., Ligibel, J. A., Lopez, G., Madan, K., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000679 · Cited by 472
Rex, D. K., Boland, C. R., Dominitz, J. A., Giardiello, F. M., Johnson, D. A., Kaltenbach, T., Levin, T. R., Lieberman, D., & Robertson, D. J. (2017) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2017.04.003 · Cited by 460
American Cancer Society prostate cancer survivorship care guidelines
Skolarus, T. A., Wolf, A. M. D., Erb, N. L., Brooks, D. D., Rivers, B. M., Underwood, W., Salner, A. L., Zelefsky, M. J., Aragon‐Ching, J. B., Slovin, S. F., et al. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21234 · Cited by 398
Clinical and molecular characterization of early‐onset colorectal cancer
Willauer, A. N., Liu, Y., Pereira, A. A. L., Lam, M., Morris, J. S., Raghav, K. P. S., Morris, V. K., Menter, D., Broaddus, R., Meric‐Bernstam, F., et al. (2019) · Cancer · doi:10.1002/cncr.31994 · Cited by 375
Cancer statistics for adults aged 85 years and older, 2019
DeSantis, C. E., Miller, K. D., Dale, W., Mohile, S. G., Cohen, H. J., Leach, C. R., Goding Sauer, A., Jemal, A., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21577 · Cited by 370
Self-citationLiang, Z.-X., Liu, H.-S., Wang, F.-W., Xiong, L., Zhou, C., Hu, T., He, X.-W., Wu, X.-J., Xie, D., Wu, X.-R., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2077-0 · Cited by 361
Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening
Katki, H. A., Kovalchik, S. A., Berg, C. D., Cheung, L. C., & Chaturvedi, A. K. (2016) · JAMA · doi:10.1001/jama.2016.6255 · Cited by 338
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study
Silverberg, M. J., Lau, B., Achenbach, C. J., Jing, Y., Althoff, K. N., D'Souza, G., Engels, E. A., Hessol, N. A., Brooks, J. T., Burchell, A. N., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2768 · Cited by 328
Ward, E. M., Sherman, R. L., Henley, S. J., Jemal, A., Siegel, D. A., Feuer, E. J., Firth, A. U., Kohler, B. A., Scott, S., Ma, J., et al. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz106 · Cited by 323
Self-citationJak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition
Groner, B., & von Manstein, V. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.033 · Cited by 306
Liu, T., Zhang, X., Gao, S., Jing, F., Yang, Y., Du, L., Zheng, G., Li, P., Li, C., & Wang, C. (2016) · Oncotarget · doi:10.18632/oncotarget.13465 · Cited by 302
Jim, M. A., Pinheiro, P. S., Carreira, H., Espey, D. K., Wiggins, C. L., & Weir, H. K. (2017) · Cancer · doi:10.1002/cncr.30881 · Cited by 300
Kumar, S., Metz, D. C., Ellenberg, S., Kaplan, D. E., & Goldberg, D. S. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.10.019 · Cited by 286
Modifiable and non-modifiable risk factors for pancreatic cancer: A review
Midha, S., Chawla, S., & Garg, P. K. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.022 · Cited by 281
The past, present, and future of cancer incidence in the United States: 1975 through 2020
Weir, H. K., Thompson, T. D., Soman, A., Møller, B., & Leadbetter, S. (2015) · Cancer · doi:10.1002/cncr.29258 · Cited by 276
Cancer Incidence Rates and Trends Among Children and Adolescents in the United States, 2001–2009
Siegel, D. A., King, J., Tai, E., Buchanan, N., Ajani, U. A., & Li, J. (2014) · Pediatrics · doi:10.1542/peds.2013-3926 · Cited by 275
The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women
Cote, M. L., Ruterbusch, J. J., Olson, S. H., Lu, K., & Ali-Fehmi, R. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0316 · Cited by 272
Leading causes of death and all-cause mortality in American Indians and Alaska Natives
Espey, D. K., Jim, M. A., Cobb, N., Bartholomew, M., Becker, T., Haverkamp, D., & Plescia, M. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301798 · Cited by 262
Temporal Trends in Mortality in the United States, 1969-2013
Ma, J., Ward, E. M., Siegel, R. L., & Jemal, A. (2015) · JAMA · doi:10.1001/jama.2015.12319 · Cited by 259
Self-citationLifestyle Medicine: A Brief Review of Its Dramatic Impact on Health and Survival
Bodai, B. I., Nakata, T. E., Wong, W. T., Clark, D. R., Lawenda, S., Tsou, C., Liu, R., Shiue, L., Cooper, N., Rehbein, M., et al. (2018) · The Permanente Journal · doi:10.7812/tpp/17-025 · Cited by 253
Nekhlyudov, L., O'malley, D. M., & Hudson, S. V. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30570-8 · Cited by 249
Kadambi, S., Loh, K. P., Dunne, R., Magnuson, A., Maggiore, R., Zittel, J., Flannery, M., Inglis, J., Gilmore, N., Mohamed, M., et al. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0421-z · Cited by 149
Structures of human steroidogenic cytochrome P450 17A1 with substrates
Petrunak, E. M., DeVore, N. M., Porubsky, P. R., & Scott, E. E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.610998 · Cited by 119
Disparities in smoking-related mortality among American Indians/Alaska Natives
Mowery, P. D., Dube, S. R., Thorne, S. L., Garrett, B. E., Homa, D. M., & Nez Henderson, P. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.05.002 · Cited by 56
Yildirim, O. A., Poyraz, K., & Erdur, E. (2021) · Quality of Life Research · doi:10.1007/s11136-021-02795-4 · Cited by 53
Reb, A., Ruel, N., Fakih, M., Lai, L., Salgia, R., Ferrell, B., Sampath, S., Kim, J. Y., Raz, D. J., & Sun, V. (2017) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2017.06.003 · Cited by 45
Cancer mortality in the oldest old: a global overview
Hashim, D., Carioli, G., Malvezzi, M., Bertuccio, P., Waxman, S., Negri, E., La Vecchia, C., & Boffetta, P. (2020) · Aging · doi:10.18632/aging.103503 · Cited by 36
Comprehensive cancer control: promoting survivor health and wellness
Rohan, E. A., Miller, N., Bonner, F., Fultz-Butts, K., Pratt-Chapman, M. L., Alfano, C. M., Santiago, K. C., Bergman, K., & Tai, E. (2018) · Cancer Causes & Control · doi:10.1007/s10552-018-1107-z · Cited by 29
The Impact of Comorbidity on Surgical Outcomes in Older Adults with Cancer
Sun, V., Burhenn, P. S., Lai, L., & Hurria, A. (2017) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2016.11.008 · Cited by 15
Fink, A. K. C., DeRenzis, A. C., Awasthi, S., Jahan, N., Johnstone, P. A. S., Pow‐Sang, J., Torres‐Roca, J., Grass, D., Fernandez, D., Naghavi, A., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.5000 · Cited by 5
Metadata
- Authors
- Edwards, B. K., Noone, A., Mariotto, A. B., Simard, E. P., Boscoe, F. P., Henley, S. J., Jemal, A., Cho, H., Anderson, R. N., Kohler, B. A., Eheman, C. R., & Ward, E. M.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2013-12-16
- Volume
- 120
- Issue
- 9
- Pages
- 1290-1314
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2107053205
- Cited by
- 1,210
- References
- 88
- FWCI
- 60.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.